PUMA BIOTECHNOLOGY INC (PBYI)
US74587V1070 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 76.75M | 84.58M | 76.20M | 63.10M | 85.30M | |||
| Marketable Securities | 30.41M | 11.35M | 4.90M | 19.00M | 8.10M | |||
| Receivables | 24.58M | 47.84M | 42.30M | 32.50M | 28.90M | |||
| Inventories | 7.10M | 7.08M | 4.50M | 7.10M | 3.50M | |||
| Other Current Assets | 4.18M | 5.33M | 6.40M | 18.30M | 20.40M | |||
| Total Current Assets | 143.03M | 156.19M | 134.30M | 140.00M | 146.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.78M | 8.65M | 12.50M | 15.80M | 18.90M | |||
| Intangibles | 58.44M | 60.87M | 70.60M | 66.10M | 74.10M | |||
| Other Non-Current Assets | 4.91M | 4.83M | 4.70M | 4.70M | 5.10M | |||
| Total Non-Current Assets | 71.12M | 74.34M | 87.80M | 86.60M | 98.10M | |||
| TOTAL ASSETS | 214.15M | 230.53M | 222.10M | 226.60M | 244.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 45.33M | 34.00M | N/A | 0.00 | 14.30M | |||
| Accrued Expenses | 42.69M | 57.52M | 69.70M | 96.10M | 85.40M | |||
| Accounts Payable | 8.96M | 6.89M | 6.40M | 11.20M | 12.10M | |||
| Other Current Liabilities | 1.21M | 975.00K | 1.40M | 2.30M | 2.50M | |||
| Total Current Liabilities | 98.19M | 99.38M | 77.50M | 109.60M | 114.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 54.69M | 65.66M | 98.30M | 97.10M | 84.00M | |||
| Other Non-Current Liabilities | 10.29M | 12.04M | 24.70M | 22.40M | 51.90M | |||
| Total Non-Current Liabilities | 64.98M | 77.70M | 123.00M | 119.40M | 135.90M | |||
| TOTAL LIABILITIES | 163.17M | 177.09M | 200.50M | 229.00M | 250.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.35B | -1.35B | -1.37B | -1.37B | -1.34B | |||
| Additional Paid In Capital | 1.40B | 1.40B | 1.39B | 1.36B | 1.33B | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -26.00K | -4.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 48.21M | 47.65M | 46.30M | 41.20M | 40.10M | |||
| Tangible Book Value per Share | -0.15 | -0.16 | -1.06 | -1.66 | -2.00 | |||
| Total Shareholders' Equity | 50.98M | 53.44M | 21.60M | -2.40M | -6.00M | |||
| TOTAL LIABILITIES AND EQUITY | 214.15M | 230.53M | 222.10M | 226.60M | 244.20M | |||
| Statistics | ||||||||
| Debt/Equity | 1.07 | 1.23 | 4.55 | -40.46 | -14.00 | |||
| Current Ratio | 1.46 | 1.57 | 1.73 | 1.28 | 1.28 | |||
| Return On Assets (ROA) | 7.18% | 9.37% | N/A | -12.84% | -24.57% | |||
| Return On Equity (ROE) | 30.17% | 40.40% | N/A | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 18.13% | 20.04% | 13.00% | 0.88% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 239.01% | 74.64% | 29.61% | 2.94% | N/A | |||
All data in USD